Phase 1 Study of IM156 in Patients With Advanced Solid Tumor and Lymphoma
Clinical trial NCT03272256 · COMPLETED
Trial details
- NCT number
- NCT03272256
- Sponsor
- ImmunoMet Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-09
- Primary completion
- 2019-12-02
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.